AN2 Therapeutics, Inc.
NASDAQ:ANTX
1.255 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 33.504 | 26.769 | 24.693 | 15.647 | 32.616 | 40.812 | 26.709 | 27.219 | 28.802 | 40.616 | 82.519 | 12.097 | -4.07 |
| Short Term Investments
| 59.922 | 77.771 | 89.517 | 91.648 | 91.202 | 54.446 | 61.806 | 68.84 | 75.58 | 72.773 | 35.835 | 46.458 | 8.14 |
| Cash and Short Term Investments
| 93.426 | 104.54 | 114.21 | 107.295 | 123.818 | 95.258 | 88.515 | 96.059 | 104.382 | 113.389 | 118.354 | 58.555 | 4.07 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.263 | 2.898 | 2.103 | 3.212 | 2.591 | 2.948 | 1.801 | 2.562 | 5.755 | 6.963 | 2.826 | 1.551 | 0 |
| Total Current Assets
| 97.689 | 107.438 | 116.313 | 110.507 | 126.409 | 98.206 | 90.316 | 98.621 | 107.296 | 116.877 | 119.783 | 60.106 | 4.07 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0.013 | 0.034 | 0.053 | 0.073 | 0.013 | 0.032 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 3.904 | 27.194 | 26.356 | 0 | 0 | 3.219 | 1.992 | 2.419 | 0 | 3.486 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 1.043 | 1.043 | 1.043 | 1.043 | 0.707 | 0.734 | 0.667 | 0.647 | 0.707 | 0.688 | 1.724 | -4.07 |
| Total Non-Current Assets
| 0 | 1.043 | 4.947 | 28.237 | 27.399 | 0.72 | 0.768 | 3.939 | 2.712 | 3.139 | 0.72 | 5.21 | -4.07 |
| Total Assets
| 97.689 | 108.481 | 121.26 | 138.744 | 153.808 | 98.926 | 91.084 | 102.56 | 110.008 | 120.016 | 120.503 | 65.316 | 0 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 1.711 | 1.885 | 2.433 | 2.676 | 4.877 | 3.131 | 3.545 | 2.122 | 1.44 | 1.612 | 2.609 | 1.063 | 0 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0.026 | 0.068 | 0.053 | 0.146 | 0.026 | 0.064 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 8.014 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 8.306 | 8.242 | 8.23 | 11.367 | 9.962 | 8.004 | 4.953 | 5.011 | 2.846 | 2.511 | 2.414 | 2.332 | 0 |
| Total Current Liabilities
| 10.017 | 10.127 | 10.663 | 14.043 | 14.839 | 11.161 | 8.566 | 7.186 | 4.432 | 4.149 | 5.087 | 3.395 | 0 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0.001 | 0.001 | 0.002 | 0.003 | 0.004 | 0.006 | 109.332 | 0 |
| Total Non-Current Liabilities
| 0 | 0 | 8.23 | 0 | 0 | 0.001 | 0.001 | 0.002 | 0.003 | 0.004 | 0.006 | 109.332 | 0 |
| Total Liabilities
| 10.017 | 10.127 | 10.663 | 14.043 | 14.839 | 11.162 | 8.567 | 7.188 | 4.435 | 4.153 | 5.093 | 112.727 | 0 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 110.008 | 120.016 | 120.503 | 109.319 | 23.07 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -198.254 | -185.507 | -171.072 | -154.455 | -137.557 | -120.85 | -105.046 | -89.723 | -77.881 | -66.542 | -56.422 | -47.384 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0.027 | 0.053 | 0.275 | -0.122 | -0.119 | -0.175 | -0.374 | -0.541 | -0.36 | -0.158 | -0.027 | -20.319 |
| Other Total Stockholders Equity
| 285.926 | 283.888 | 281.616 | 278.881 | 276.648 | 208.733 | 187.738 | 185.469 | 183.995 | 182.765 | 171.99 | -109.319 | 0 |
| Total Shareholders Equity
| 87.672 | 98.354 | 110.597 | 124.701 | 138.969 | 87.764 | 82.517 | 95.372 | 105.573 | 115.863 | 115.41 | -47.411 | 2.751 |
| Total Equity
| 87.672 | 98.354 | 110.597 | 124.701 | 138.969 | 87.764 | 82.517 | 95.372 | 105.573 | 115.863 | 115.41 | -47.411 | 2.751 |
| Total Liabilities & Shareholders Equity
| 97.689 | 108.481 | 121.26 | 138.744 | 153.808 | 98.926 | 91.084 | 102.56 | 110.008 | 120.016 | 120.503 | 65.316 | 2.751 |